Table 1.
Clinical data and inflammatory parameters of the four study groups (median [interquartile range]).
Figure 1.
Circulating CRP (A), suPAR (B) and IL-6 (C) levels measured in healthy non-pregnant and pregnant, and asthmatic non-pregnant and pregnant subjects.
HNP – healthy non-pregnant; HP – healthy pregnant; ANP – asthmatic non-pregnant; AP – asthmatic pregnant; CRP – C-reactive protein; suPAR – soluble urokinase plasminogen activator receptor; IL-6 – interleukin 6; ap<0.05 vs. HNP, bp<0.05 vs. HP and cp<0.05 vs. ANP.
Figure 2.
Positive correlation of airway resistance (Raw) to circulating suPAR (A) and to circulating IL-6 (B) levels in asthmatic non-pregnant patients.
suPAR – soluble urokinase plasminogen activator receptor; IL-6 – interleukin 6.
Figure 3.
ROC analyses of suPAR values in asthmatic non-pregnant patients (A, B) and asthmatic pregnant patients (C, D) with good and impaired asthma control.
ANP – asthmatic non-pregnant, AP – asthmatic pregnant; PEF – peak expiratory flow rate, ACT – Asthma Control Test total score.
Table 2.
Cut-off values of the inflammatory markers.